Canaan Partners is a venture capital firm with a strong presence on both the East and West Coasts. In New York, they focus on early-stage investments in technology, healthcare, and other industries. Canaan Partners' commitment to nurturing innovation has made them an influential player in the city's venture capital landscape.
Canaan Partners is a prominent venture capital firm that invests in early-stage startups across healthcare and technology sectors. Founded in 1987, Canaan Partners has built a strong reputation for backing visionary entrepreneurs who are creating groundbreaking products and solutions. With a focus on long-term partnerships, Canaan provides capital, strategic guidance, and operational expertise to help startups navigate the challenges of scaling and achieving market success.
In the healthcare sector, Canaan Partners invests in companies developing innovative solutions in biotechnology, digital health, medical devices, and diagnostics. The firm seeks out startups that are transforming patient care, advancing medical research, and addressing unmet healthcare needs. Canaan has played a pivotal role in helping healthcare companies bring life-saving therapies and technologies to market.
In the technology space, Canaan Partners backs startups in fintech, enterprise software, consumer internet, and e-commerce. The firm is known for investing in disruptive companies that are reshaping industries, improving efficiency, and creating new opportunities for growth. Canaan’s tech portfolio includes some of the most successful startups in these sectors, helping them grow from early-stage ventures to industry leaders.
Canaan Partners takes a hands-on approach to investing, working closely with founders to provide mentorship, operational support, and access to a vast network of industry experts and partners. This collaborative model has contributed to the firm’s long track record of successful exits, including IPOs and acquisitions.
Our pitch deck template will guide you through the requirements of an Accelerator-ready presentation.
SOSV is a global venture capital firm in NYC, Newark, and San Francisco, with $1.5B AUM, focusing on early-stage startups in deep tech, hard tech, and life sciences. They offer pre-seed/seed funding of $250K to $525K and boast a diverse portfolio of 1,000+ companies, supporting human and planetary health, with flagship programs like HAX and IndieBio providing extensive resources.
